Avidity Partners 13F holdings, Q2 2021
Holdings as of June 30, 2021 · filings on SEC EDGAR · latest filing →
Avidity Partners disclosed 112 US equity positions worth $3.7bn in its Q2 2021 13F filing. The largest position was VRTX at 5.2% of the reported book, followed by ABBV and ARVN. Against the Q1 2021 filing, it opened 16 new positions, added to 19 and reduced 15 among the top 50 holdings.
What did Avidity Partners own in Q2 2021? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2021 |
|---|---|---|---|---|---|---|---|
| 1 | VRTX VERTEX PHARMACEUTICALS INC. | Healthcare | 5.2% | $191.5m | 950,000 | 206% | added |
| 2 | ABBV ABBVIE INC | Healthcare | 4.5% | $167.2m | 1,484,400 | -29% | reduced |
| 3 | ARVN ARVINAS INC | Healthcare | 3.9% | $142.8m | 1,854,000 | 5% | added |
| 4 | LLY LILLY ELI & CO | Healthcare | 3.5% | $129.8m | 565,500 | – | new |
| 5 | MRVI MARAVAI LIFESCIENCES HLDGS I | Healthcare | 3.3% | $123.7m | 2,963,545 | 7% | added |
| 6 | MIRATI THERAPEUTICS INC | 3.3% | $121.6m | 753,000 | 58% | added | |
| 7 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 3.1% | $114.9m | 2,160,000 | 71% | added |
| 8 | AVTR AVANTOR INC | Healthcare | 3.1% | $112.9m | 3,180,000 | -36% | reduced |
| 9 | SEAGEN INC | 2.7% | $101.0m | 640,000 | 11% | added | |
| 10 | BIOHAVEN PHARMACTL HLDG CO L | 2.3% | $85.7m | 882,500 | -16% | reduced | |
| 11 | HO1 HOLOGIC INC | 2.2% | $80.7m | 1,208,800 | – | new | |
| 12 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.1% | $79.2m | 4,615,000 | 20% | added |
| 13 | ESSA PHARMA INC | 2.1% | $78.6m | 2,750,000 | -3% | reduced | |
| 14 | EXK EXACT SCIENCES CORP | Basic Materials | 2.0% | $73.3m | 590,000 | -1% | reduced |
| 15 | MDT MEDTRONIC PLC | Healthcare | 1.8% | $66.4m | 535,000 | -48% | reduced |
| 16 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.8% | $66.3m | 681,000 | 31% | added |
| 17 | NUVB NUVATION BIO INC | Healthcare | 1.8% | $64.9m | 6,966,376 | -7% | reduced |
| 18 | ARENA PHARMACEUTICALS INC | 1.7% | $64.3m | 943,000 | 5% | added | |
| 19 | BIIB BIOGEN INC | Healthcare | 1.7% | $63.7m | 183,900 | – | new |
| 20 | NEO NEOGENOMICS INC | Healthcare | 1.7% | $61.7m | 1,367,000 | – | new |
| 21 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 1.7% | $61.5m | 380,000 | – | new |
| 22 | NBP I MAB | Healthcare | 1.7% | $61.2m | 729,000 | -45% | reduced |
| 23 | CATALENT INC | 1.6% | $58.4m | 540,000 | -4% | reduced | |
| 24 | STTK SHATTUCK LABS INC | Healthcare | 1.5% | $56.2m | 1,940,200 | 46% | added |
| 25 | CNC CENTENE CORP DEL | Healthcare | 1.5% | $54.8m | 751,200 | – | new |
| 26 | HORIZON THERAPEUTICS PUB L | 1.4% | $53.2m | 568,000 | -2% | reduced | |
| 27 | 2655787D BLUEPRINT MEDICINES CORP | 1.3% | $49.5m | 563,200 | 3% | added | |
| 28 | NTRA NATERA INC | Healthcare | 1.3% | $49.5m | 436,000 | 10% | added |
| 29 | SHC SOTERA HEALTH CO | Healthcare | 1.3% | $46.3m | 1,910,000 | 65% | added |
| 30 | XLRN ACCELERON PHARMA INC | 1.2% | $45.0m | 358,500 | 11% | added | |
| 31 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.2% | $43.4m | 2,070,000 | 41% | added |
| 32 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.1% | $42.4m | 236,400 | – | new |
| 33 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.1% | $41.0m | 673,400 | -17% | reduced |
| 34 | ATEC ALPHATEC HLDGS INC | Healthcare | 1.1% | $40.2m | 2,621,000 | 12% | added |
| 35 | TRILLIUM THERAPEUTICS INC | 1.1% | $39.8m | 4,105,000 | 2% | added | |
| 36 | CYTEIR THERAPEUTICS INC | 1.0% | $38.7m | 1,808,394 | – | new | |
| 37 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.0% | $38.1m | 1,000,000 | – | new |
| 38 | CAH CARDINAL HEALTH INC | Healthcare | 1.0% | $37.3m | 654,200 | -55% | reduced |
| 39 | KDMN KADMON HLDGS INC | 1.0% | $36.0m | 9,294,600 | -3% | reduced | |
| 40 | DVAX DYNAVAX TECHNOLOGIES CORP | 0.9% | $33.5m | 3,400,000 | -3% | reduced | |
| 41 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.9% | $33.1m | 195,000 | -54% | reduced |
| 42 | INSM INSMED INC | Healthcare | 0.9% | $32.7m | 1,150,050 | – | new |
| 43 | SEASPINE HLDGS CORP | 0.8% | $31.3m | 1,524,998 | – | new | |
| 44 | LFST LIFESTANCE HEALTH GROUP INC | Healthcare | 0.8% | $30.6m | 1,100,000 | – | new |
| 45 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.8% | $29.4m | 1,003,522 | – | new |
| 46 | LEGN LEGEND BIOTECH CORP | Healthcare | 0.7% | $25.7m | 625,000 | – | new |
| 47 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 0.6% | $23.5m | 601,000 | 9% | added |
| 48 | ACET ADICET BIO INC | Healthcare | 0.6% | $23.2m | 2,250,500 | 1% | added |
| 49 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.6% | $22.9m | 940,000 | – | new |
| 50 | GRAPHITE BIO INC | 0.6% | $22.6m | 735,500 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.